Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 6/7/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Werner Lubitz?

Werner Lubitz

Chief Executive Officer and Chief Scientific Officer

BIRD-C GmbH & CoKEG

Direct Phone: +43 * *********direct phone

Email: w***@***.at

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

BIRD-C GmbH & CoKEG

Vienna,

Austria

Company Description

BIRD-C is developing a novel BG Cancer Immunotherapy (BGCI) based on selected BGs loaded with chemotherapeutics such as Oxaliplatin. The therapy is given through intratumoral injection or applied in close proximity to the tumor. BGCI destroys cancer cells th...more

Web References(9 Total References)


+++ B I R D - C +++

bird-c.com [cached]

Werner Lubitz, PhD
Chief Executive Officer (CEO) and Chief Scientific Officer (CSO) Prof. Dr. Werner Lubitz holds an MSc and a PhD in Microbiology and Genetics from the Technical University of Munich, Germany. He obtained his postdoctoral training at the Universities of Lausanne and Basel, Switzerland; Uppsala, Sweden; Victoria, Canada and at the Max Planck Institute for Psychiatry, Munich, Germany. Dr. Lubitz was an Associate Professor of Microbiology at the University of Kaiserslautern, Germany and Associate Professor of Genetics at the University of Munich, Germany. Since 1987, he has been a Full Professor at the University of Vienna, Austria, first at the Institute of Microbiology and Genetics, and recently at the Department of Medicinal Chemistry. Werner Lubitz has published more than 100 papers in internationally peer-reviewed journals. As inventor of the Bacterial Ghost Platform Technology he holds an extensive international patent portfolio. In 1998, Dr. Lubitz founded the biotech company BIRD-C in Vienna.


700 for Science

www.700forscience.com [cached]

Werner Lubitz
CEO and Founder, Bird-C


www.700forscience.com

Dr. Werner Lubitz
CEO and Founder, Bird-C Austria Send a Message Dr. Lubitz is the inventor of the bacterial ghost platform technology, which is enabling the development of a new generation of safe, effective vaccines and drug delivery vehicles based on bacterial ghosts - empty, non-living envelopes of Gram-negative bacteria.


+++ B I R D - C +++

www.bird-c.com [cached]

Werner Lubitz,


Future Drugs

www.future-drugs.com [cached]

Katri Jalava|, Francis O Eko, Eva Riedmann and Werner Lubitz· Werner Lubitz, Professor, BIRD-C GmbH & CoKEG, Schoenborngasse 12, A-1080 Wien, Austria and Institute of Microbiolgy and Genetics, University of Vienna, Austria.Figure 1.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory